BRIEF-GlaxoSmithKline reports submission for UMEC in EU

LONDON, April 26 Fri Apr 26, 2013 5:03am EDT

Related Topics

LONDON, April 26 (Reuters) - GlaxoSmithKline Plc : * Regulatory submission for umeclidinium monotherapy in European union * Regulatory filings for umec monotherapy are imminent in the US and planned in

other countries during 2013

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.